XML 43 R22.htm IDEA: XBRL DOCUMENT v3.25.4
Restructuring
12 Months Ended
Jan. 02, 2026
Restructuring and Related Activities [Abstract]  
RESTRUCTURING RESTRUCTURING
In August 2025, our Board of Directors authorized, and we implemented, a corporate reorganization plan (the 2025 Plan) to reorganize our workforce and close our office located in King of Prussia, Pennsylvania. Restructuring expenses incurred under the 2025 Plan are primarily severance and employee-related costs. The total restructuring costs, incurred during the year ended December 31, 2025, associated with the 2025 Plan were $20.5 million and are presented in the restructuring expense line item within our Consolidated Statements of Income. We incurred the majority of the costs related to the 2025 Plan during the third quarter of 2025 and substantially completed the 2025 Plan by the end of the fiscal year 2025.
The restructuring activities and balances as of and for the year ended December 31, 2025, were as follows (in thousands):
Year Ended December 31, 2025
Accrued at
December 31, 2024
Initial Costs
Adj. to Costs(2)
Non-cash chargesCash Payments
Accrued at
December 31, 2025(3)
Total Costs Incurred to DateTotal Expected Plan Costs
Severance and employee-related costs and other exit costs(1)
$— $20,337 $173 $(395)$(17,470)$2,645 $20,510 $20,510 
Other restructuring plan(4)
256 — — — (256)— — — 
Total restructuring$256 $20,337 $173 $(395)$(17,726)$2,645 $20,510 $20,510 
__________________
(1) Other exit costs expensed as incurred.
(2) Adjustments to costs consist of changes in estimates whereby increases and decreases in costs were recorded to operating expenses in the period of adjustments.
(3) As of December 31, 2025, substantially all restructuring liabilities have been recorded in accrued compensation and benefits in the accompanying Consolidated Balance Sheets.
(4) Consisted of severance and employee-related costs from the 2024 Plan (as defined below), paid in the first quarter of 2025.
In January 2024, our Board of Directors authorized, and we implemented, a corporate restructuring plan (the 2024 Plan) to reduce our workforce and rebalance our cost structure in alignment with our strategic priorities. Restructuring expenses incurred under the 2024 Plan included: severance and employee-related costs; impairment of long-lived assets; and contract termination and other exit costs. The total restructuring costs, incurred during the year ended December 31, 2024, associated with the 2024 Plan were $33.7 million in expenses and were recorded to the restructuring expense line item within our Consolidated Statements of Income as they were incurred through the end of the plan. We incurred the majority of the costs related to the 2024 Plan during the first quarter of 2024.
In connection with the 2024 Plan, we exited two leases in the Greater Philadelphia area and the right-of-use assets, related leasehold improvements and certain other long-lived assets were remeasured and recorded at fair value, see “Note 12. Commitments and Contingencies” for additional information.
The restructuring activities and balances as of and for the year ended December 31, 2024, were as follows (in thousands):
Year Ended December 31, 2024
Accrued at
December 31, 2023
Initial Costs
Adj. to Costs(2)
Non-cash chargesCash Payments
Accrued at
December 30, 2024(3)
Total Costs Incurred to DateTotal Expected Plan Costs
Severance and employee-related costs$— $15,656 $69 $— $(15,469)$256 $15,725 $15,725 
Contract termination and other exit costs(1)
— 5,220 (4)— (5,216)— 5,216 5,216 
Asset impairment — 12,318 401 (12,719)— — 12,719 12,719 
Total restructuring$— $33,194 $466 $(12,719)$(20,685)$256 $33,660 $33,660 
__________________
(1) Contract termination costs consist of accruals for costs to be incurred without future economic benefit, and other exit costs expensed as incurred.
(2) Adjustments to costs consist of changes in estimates whereby increases and decreases in costs were recorded to operating expenses in the period of adjustments.
(3) As of December 31, 2024, all restructuring liabilities have been recorded in accrued compensation and benefits in the accompanying Consolidated Balance Sheets.